Back to Search
Start Over
New Phase of Mab Biosimilar Knocks the Door for Biosimilar Opportunities In Japan
- Source :
- PR Newswire. January 21, 2015
- Publication Year :
- 2015
-
Abstract
- MUMBAI, January 21, 2015 /PRNewswire/ -- The launch of Remicade biosimilar in Dec-2014 in the Japan pharma market demonstrated its changing regulatory environment; it is faster than U.S. in adapting [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PR Newswire
- Publication Type :
- News
- Accession number :
- edsgcl.398244775